08/25/2022 | Press release | Distributed by Public on 08/25/2022 00:43
Ortivus: - An expansive e-Health company
Highlights April - June 2022
Significant events after end of the period
April - June 2022
January - June 2022
Apr-Jun 2022 | Apr-Jun 2021 | Jan-Jun 2022 | Jan-Jun 2021 | Jan-Dec 2022 | |
Net sales (MSEK) | 26.4 | 23.6 | 51.0 | 47.1 | 94.3 |
Gross margin (%) | 57% | 49% | 53% | 49% | 51% |
Operating profit (MSEK) | 3.5 | 3.2 | 5.5 | 4.9 | 9.3 |
Operating margin (%) | 13% | 13% | 11% | 10% | 10% |
EBITDA (MSEK) | 4.4 | 3.5 | 6.8 | 5.5 | 12.7 |
Contacts
For further information, please contact
Reidar Gårdebäck, CEO
Telefon +46 8 446 45 00
About Ortivus
Ortivus develops and commercialises MobiMed, medical technology solutions for a safer and more efficient
healthcare. The company was founded in 1985 and is today a leading provider of mobile digital
solutions for prehospital care, worldwide. Ortivus' products are based on in-depth expertise
in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm and the company has, since 1998, a wholly-owned subsidiary based in the United Kingdom.
MobiMed is a modular platform that currently is used by over 12,000 paramedics in over 2,700 emergency vechicles. The platform consists of a monitor that in real-time measures, monitors and shares patients'
vital parameters, such as, ECG, blood pressure and blood oxygenation. The system also consists
of an electronic patient record for decision support, collection of patient data and clinical documentation.
MobiMed has a total weight of 3.5kg and is created to function in a demanding environment and out in
the field. The two-way communication supports telemedicine consulting with clinical experts while patient data is seamlessly integrated into the medical records at the hospitals and primary care centers. MobiMed saves time and helps healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.
Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.
Read more about Ortivus at www.ortivus.com
This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-08-25 08:30 CEST.
Attachments